Shares of Motus GI Holdings Inc (NASDAQ:MOTS) reached a new 52-week low on Thursday . The company traded as low as $3.59 and last traded at $3.78, with a volume of 43979 shares traded. The stock had previously closed at $3.83.
A number of equities analysts have recently commented on the stock. Zacks Investment Research lowered shares of Motus GI from a “hold” rating to a “sell” rating in a research report on Wednesday, July 18th. Oppenheimer set a $10.00 target price on shares of Motus GI and gave the stock a “buy” rating in a research report on Wednesday, August 15th. Dougherty & Co assumed coverage on shares of Motus GI in a research report on Tuesday, August 28th. They set a “buy” rating and a $8.00 target price on the stock. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $8.00 target price on shares of Motus GI in a research report on Tuesday, August 14th. Finally, LADENBURG THALM/SH SH assumed coverage on shares of Motus GI in a research report on Thursday, August 30th. They set a “buy” rating and a $14.50 target price on the stock. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $10.50.
The stock has a market capitalization of $60.05 million and a P/E ratio of -2.85.
Motus GI (NASDAQ:MOTS) last issued its earnings results on Tuesday, August 14th. The company reported ($0.27) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.26) by ($0.01). The firm had revenue of $0.03 million for the quarter. On average, analysts forecast that Motus GI Holdings Inc will post -1.01 EPS for the current fiscal year.
Several large investors have recently modified their holdings of the company. Private Advisor Group LLC purchased a new position in shares of Motus GI during the third quarter worth approximately $105,000. Quantitative Systematic Strategies LLC purchased a new position in shares of Motus GI during the second quarter worth approximately $113,000. Finally, IPG Investment Advisors LLC purchased a new position in shares of Motus GI during the second quarter worth approximately $106,000. 21.61% of the stock is currently owned by institutional investors and hedge funds.
Motus GI Company Profile (NASDAQ:MOTS)
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Further Reading: Hedge Funds Explained
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.